Literature DB >> 8483201

Late invasive recurrence despite long-term surveillance for superficial bladder cancer.

R A Thompson1, E W Campbell, H C Kramer, S C Jacobs, M J Naslund.   

Abstract

Superficial transitional cell carcinoma of the bladder is associated with a 15 to 70% recurrence rate within 2 years. Most recurrences are superficial. A recurrence after 2 disease-free years is unusual. A review of the tumor registry revealed 124 patients followed for superficial disease at the Veterans Administration Center in Baltimore. Of the patients 20 were identified with either stage Ta (7) or stage T1 (13) papillary transitional cell carcinoma who had completed at least 5 years of surveillance without tumor recurrence. Invasive transitional cell carcinoma of the bladder requiring cystectomy developed in 7 of these 20 patients after remaining tumor-free for 5 years (stage Ta in 4 and stage T1 in 3). All 7 patients had organ-confined disease and were alive with no evidence of disease at 18 months to 5 years after cystectomy. These results demonstrate that superficial, low grade transitional cell carcinoma of the bladder can become muscle invasive despite careful surveillance and a long dormant period. In our series yearly cystoscopy and urine cytology identified tumor recurrence before metastases developed, suggesting that long-term surveillance is required in patients with superficial bladder cancer.

Entities:  

Mesh:

Year:  1993        PMID: 8483201     DOI: 10.1016/s0022-5347(17)36282-1

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  8 in total

Review 1.  Current problems and needs in the treatment of pT1 G3 bladder carcinoma.

Authors:  Francisco Jose Martínez Portillo; Peter Alken
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

Review 2.  Chemoprevention of bladder cancer.

Authors:  Dragan J Golijanin; David Kakiashvili; Ralph R Madeb; Edward M Messing; Seth P Lerner
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

Review 3.  Natural history of superficial bladder tumors: 10- to 20-year follow-up of treated patients.

Authors:  H W Herr
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

4.  Bladder cancer 2000: molecular markers for the diagnosis of transitional cell carcinoma.

Authors:  D Chao; S J Freedland; A J Pantuck; A Zisman; A S Belldegrun
Journal:  Rev Urol       Date:  2001

5.  What is the ratio of urethral recurrence risk after radical cystoprostatectomy for bladder cancer?

Authors:  Güven Sevin; Sedat Soyupek; Abdullah Armağan; Mustafa Burak Hoşcan; Cem Dilmen; Osman Tükel
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

6.  Cytological findings in routine voided urine samples with hematuria from a tertiary care center in south India.

Authors:  Sujatha Siddappa; Km Mythri; R Kowsalya
Journal:  J Cytol       Date:  2012-01       Impact factor: 1.000

7.  Prognostic utility of human complement factor H related protein test (the BTA stat Test).

Authors:  M P Raitanen; E Kaasinen; E Rintala; E Hansson; P Nieminen; R Aine; T L Tammela
Journal:  Br J Cancer       Date:  2001-08-17       Impact factor: 7.640

8.  Cytogenetic monoclonality in multifocal uroepithelial carcinomas: evidence of intraluminal tumour seeding.

Authors:  I Fadl-Elmula; L Gorunova; N Mandahl; P Elfving; R Lundgren; F Mitelman; S Heim
Journal:  Br J Cancer       Date:  1999-09       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.